207 related articles for article (PubMed ID: 34661962)
21. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
Su CC
Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
[TBL] [Abstract][Full Text] [Related]
22. Growth-inhibiting and apoptosis-inducing effects of Tanshinone II A on human gastric carcinoma cells.
Dong X; Dong J; Peng G
J Huazhong Univ Sci Technolog Med Sci; 2007 Dec; 27(6):706-9. PubMed ID: 18231749
[TBL] [Abstract][Full Text] [Related]
23. Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway.
He L; Liu YY; Wang K; Li C; Zhang W; Li ZZ; Huang XZ; Xiong Y
Biochem Biophys Res Commun; 2021 Oct; 575():1-7. PubMed ID: 34454174
[TBL] [Abstract][Full Text] [Related]
24. Potential anticancer activity of tanshinone IIA against human breast cancer.
Wang X; Wei Y; Yuan S; Liu G; Lu Y; Zhang J; Wang W
Int J Cancer; 2005 Sep; 116(5):799-807. PubMed ID: 15849732
[TBL] [Abstract][Full Text] [Related]
25. Tanshinone I induces apoptosis and pro-survival autophagy in gastric cancers.
Jing X; Xu Y; Cheng W; Guo S; Zou Y; He L
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1171-81. PubMed ID: 27100736
[TBL] [Abstract][Full Text] [Related]
26. CircRPPH1 promotes the stemness of gastric cancer cells by targeting miR-375/SLC7A11 axis.
Liu J; Yang H; Deng J; Jiang R; Meng E; Wu H
Environ Toxicol; 2023 Jan; 38(1):115-125. PubMed ID: 36190453
[TBL] [Abstract][Full Text] [Related]
27. Tanshinone IIA regulates microRNA‑125b/foxp3/caspase‑1 signaling and inhibits cell viability of nasopharyngeal carcinoma.
Wang Y; Jin W; Wang J
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760137
[TBL] [Abstract][Full Text] [Related]
28. Anticancer effects of tanshinone I in human non-small cell lung cancer.
Lee CY; Sher HF; Chen HW; Liu CC; Chen CH; Lin CS; Yang PC; Tsay HS; Chen JJ
Mol Cancer Ther; 2008 Nov; 7(11):3527-38. PubMed ID: 19001436
[TBL] [Abstract][Full Text] [Related]
29. GDF15 knockdown promotes erastin-induced ferroptosis by decreasing SLC7A11 expression.
Chen L; Qiao L; Bian Y; Sun X
Biochem Biophys Res Commun; 2020 May; 526(2):293-299. PubMed ID: 32209255
[TBL] [Abstract][Full Text] [Related]
30. Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/ERK/TRIB3 pathway.
Zhang W; Liu M; Ji Y; Yu D; Ma C; Zhao J; Qu P
Arch Biochem Biophys; 2023 Jul; 743():109655. PubMed ID: 37285895
[TBL] [Abstract][Full Text] [Related]
31. Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells.
Ren X; Wang C; Xie B; Hu L; Chai H; Ding L; Tang L; Xia Y; Dou X
Eur J Pharmacol; 2017 Feb; 796():233-241. PubMed ID: 27894814
[TBL] [Abstract][Full Text] [Related]
32. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
Won SH; Lee HJ; Jeong SJ; Lü J; Kim SH
Phytother Res; 2012 May; 26(5):669-74. PubMed ID: 21997969
[TBL] [Abstract][Full Text] [Related]
33. Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway.
Su CC
Int J Mol Med; 2018 Apr; 41(4):2389-2396. PubMed ID: 29393362
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone IIA May Inhibit Gastric Cancer via Affecting the Intestinal Microbiome.
Lu F; Zhang Y; Song P; Xu Y; Wu Z; Wang Q; Shen N
Comput Math Methods Med; 2022; 2022():6960304. PubMed ID: 36199775
[TBL] [Abstract][Full Text] [Related]
35. Tanshinone IIA attenuates high glucose induced human VSMC proliferation and migration through miR-21-5p-mediated tropomyosin 1 downregulation.
Jia S; Ma WD; Zhang CY; Zhang Y; Yao ZH; Quan XH; Guo X; Wang CX
Arch Biochem Biophys; 2019 Nov; 677():108154. PubMed ID: 31672498
[TBL] [Abstract][Full Text] [Related]
36. In vitro anti-tumor activity of the tanshinone IIA against SKOV3 cells.
Huang J; Lin H; Hong Y
Nat Prod Res; 2016 Aug; 30(16):1844-6. PubMed ID: 26252372
[TBL] [Abstract][Full Text] [Related]
37. Tanshinone IIA reverses the malignant phenotype of SGC7901 gastric cancer cells.
Xu M; Cao FL; Li NY; Liu YQ; Li YP; Lv CL
Asian Pac J Cancer Prev; 2013; 14(1):173-7. PubMed ID: 23534719
[TBL] [Abstract][Full Text] [Related]
38. Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway.
Xie Z; He B; Jiang Z; Zhao L
J Recept Signal Transduct Res; 2020 Dec; 40(6):591-598. PubMed ID: 32496906
[TBL] [Abstract][Full Text] [Related]
39. Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer.
Xu X; Li Y; Wu Y; Wang M; Lu Y; Fang Z; Wang H; Li Y
Redox Biol; 2023 Feb; 59():102564. PubMed ID: 36473315
[TBL] [Abstract][Full Text] [Related]
40. Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway.
Ma L; Jiang H; Xu X; Zhang C; Niu Y; Wang Z; Tao Y; Li Y; Cai F; Zhang X; Wang X; Yu Y
Aging (Albany NY); 2019 Nov; 11(21):9719-9737. PubMed ID: 31711043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
